BENJAMIN JAVERY: Open Payments
NPI 1477077493 · PAWTUCKET, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$480 in 16 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $480
Food & beverage: $480
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $260 |
| Verona Pharma, Inc. | 3 | $86 |
| Amgen Inc. | 2 | $37 |
| Baxter Healthcare | 1 | $31 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $28 |
| Philips North America LLC | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $13 |
Products named: TEZSPIRE, Ohtuvayre, FASENRA, JASCAYD, Vest Therapy Und, ZERBAXA.
Industry payments across RI — which companies pay providers there.
